Literature DB >> 1381724

Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.

T K Weber1, G Steele, I C Summerhayes.   

Abstract

The results presented in this report demonstrate increased pp60c-src kinase activity associated with moderate to well differentiated colon tumors, corroborating previous observations by other groups. Extension of this analysis to include a small number of poorly differentiated colon carcinomas revealed src kinase activity comparable to that observed in normal colonic mucosa, considerably less than that observed in moderate/well differentiated lesions. Correlations of src kinase activity with differentiation was confirmed within a panel of colon cell lines where increased activity, associated with moderate/well differentiated lines, was accompanied by increased expression of pp60c-src protein. Use of an antiphosphotyrosine antibody in immunoprecipitation revealed the presence of novel phosphotyrosyl cellular substrates in human colon cell lines displaying elevated pp60c-src kinase activity. These observations suggest a role for the src protooncogene in colonic differentiation pathways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381724      PMCID: PMC329935          DOI: 10.1172/JCI115956

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.

Authors:  N Rosen; J B Bolen; A M Schwartz; P Cohen; V DeSeau; M A Israel
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

2.  Tyr527 is phosphorylated in pp60c-src: implications for regulation.

Authors:  J A Cooper; K L Gould; C A Cartwright; T Hunter
Journal:  Science       Date:  1986-03-21       Impact factor: 47.728

3.  Activation of the transforming potential of p60c-src by a single amino acid change.

Authors:  J B Levy; H Iba; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells.

Authors:  C Bjelfman; G Meyerson; C A Cartwright; K Mellström; U Hammerling; S Påhlman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

5.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

6.  Neurones express high levels of a structurally modified, activated form of pp60c-src.

Authors:  J S Brugge; P C Cotton; A E Queral; J N Barrett; D Nonner; R W Keane
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

7.  Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product.

Authors:  J B Bolen; N Rosen; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation.

Authors:  K Mellström; C Bjelfman; U Hammerling; S Påhlman
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

9.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

10.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  12 in total

Review 1.  Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors:  S B Noonberg; C C Benz
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

2.  SSO Clinical Award Lecture. The surgical oncologist as a key translator of basic biology to patients with gastrointestinal cancer: asking the right questions.

Authors:  G Steele
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

3.  Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.

Authors:  Yong-Wen Huang; Chen Chen; Man-Man Xu; Jun-Dong Li; Juan Xiao; Xiao-Feng Zhu
Journal:  Mol Cell Biochem       Date:  2013-01-01       Impact factor: 3.396

4.  NMT1 (N-myristoyltransferase 1).

Authors:  Ponniah Selvakumar; Sujeet Kumar; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2011-01-07

5.  Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.

Authors:  Li Zhang; Baofei Jiang; Ni Zhu; Mingyue Tao; Yali Jun; Xiaofei Chen; Qilong Wang; Chao Luo
Journal:  Med Oncol       Date:  2019-11-13       Impact factor: 3.064

Review 6.  N-myristoyltransferase in the leukocytic development processes.

Authors:  Sujeet Kumar; Baljit Singh; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Cell Tissue Res       Date:  2011-06-24       Impact factor: 5.249

7.  Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.

Authors:  Melinda D Willard; Mary E Lajiness; Isabella H Wulur; Bo Feng; Michelle L Swearingen; Mark T Uhlik; Kenneth W Kinzler; Victor E Velculescu; Tobias Sjöblom; Sanford D Markowitz; Steven M Powell; Bert Vogelstein; Thomas D Barber
Journal:  Mol Cancer Res       Date:  2012-04-19       Impact factor: 5.852

8.  Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.

Authors:  Thanemozhi G Natarajan; Bhaskar V Kallakury; Christine E Sheehan; Margaret B Bartlett; Natarajan Ganesan; Anju Preet; Jeffrey S Ross; Kevin T FitzGerald
Journal:  Cancer Cell Int       Date:  2010-04-30       Impact factor: 5.722

9.  The potential use of N-myristoyltransferase as a biomarker in the early diagnosis of colon cancer.

Authors:  Sujeet Kumar; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Cancers (Basel)       Date:  2011-03-16       Impact factor: 6.639

10.  Elevated c-Src and c-Yes expression in malignant skin cancers.

Authors:  Jang Hyun Lee; Jae-Kyung Pyon; Dong Wook Kim; Sang Han Lee; Hae Seon Nam; Chul Han Kim; Sang Gue Kang; Yoon Jin Lee; Mi Youn Park; Dong Jun Jeong; Moon Kyun Cho
Journal:  J Exp Clin Cancer Res       Date:  2010-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.